Working to provide information, support and access to established, new or innovative treatments for Atrial Fibrillation (AF)
Our Founder Trudie Lobban MBE was live this morning on BBC Radio Oxford
Listen to Our Founder Trudie Lobban MBE on her Park Radio Interview on Sunday
Stressful jobs are associated with a higher risk of heart rhythm disorders
Symptoms include palpitations, weakness, fatigue, feeling light headed, dizziness, and shortness of breath. Atrial fibrillation causes 20–30% of all ...
Apixaban is a safe alternative to warfarin during catheter ablation of atrial fibrillation and may have a positive effect on cognitive function
Apixaban and warfarin are equally safe during catheter ablation of atrial fibrillation, according to results of the AXAFA-AFNET 5 (Anticoagulation using the direct factor Xa inhibitor apixaban during Atrial Fibrillation catheter Ablation: Comparison to vitamin K antagonist therapy) (German Atrial Fibrillation NETwork (AFNET)) trial presented at European Heart Rhythm Association Congress (EHRA; 18–20 March 2018, Barcelona, Spain). There were similar rates of stroke and bleeding, and an improvement in cognitive function was shown for the first time.
Take Fainting to Heart
But if there is no explanation and someone has a history of unexplained fainting, there is a chance that it could be down to an arrhythmia. Sudden ...
Trudie Lobban MBE, Founder and CEO, Arrhythmia Alliance Media Tour
Watch Trudie Lobban MBE, discuss the importance of being pulse aware on her US media tour.
New study: AFib and noise may be linked
Atrial fibrillation (AFib) is the most common type of heart arrhythmia. About 2.7 to 6.1 million people in the United States have AFib, and with the aging ...
May Medical e-News 2018
All the latest updates, reminders and news from us in one place.
GPs urged to check patients' pulse in bid to cut strokes
People with atrial fibrillation have a significantly higher risk of stroke, but if they have been diagnosed then they can be given medication to control ...
Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies
Patients with resolved atrial fibrillation remain at higher risk of stroke or TIA than patients without atrial fibrillation. The risk is increased even in those in whom recurrent atrial fibrillation is not documented. Guidelines should be updated to advocate continued use of anticoagulants in patients with resolved atrial fibrillation.